April 27, 2010

colorectal cancer

Speakers:
Prof Wendy Atkin, Professor in Division of Surgery, Imperial College London
Prof Jane Wardle, Director, Cancer Research UK Health Behaviour Centre
Harpal Kumar, Chief Executive, Cancer Research UK
Prof Max Parmar, Director, Medical Research Council Clinical Trials Unit

Colorectal cancer is the third most frequently diagnosed cancer worldwide, and a major cause of death, but the value of screening programmes continues to be a source of much debate. In new research published in The Lancet, researchers have announced the findings of a UK-based trial, which started 16 years ago, to assess the merit of a single sigmoidoscopy lower bowel examination in patients aged 55-64 years to screen for colorectal cancer.